The 6th International Online Conference on Nutrients
Innovations in Neonatal and Early Childhood Nutrition
Part of the International Online Conference on Nutrients series
10–11 February 2027
12 October 2026
10 November 2026
5 February 2027
Breast milk, Growth, Infant development, Macronutrients, Micronutrients, Bioactives
- Go to the Sessions
-
- S1. Human Milk Composition and Its Role in Infant Development
- S2. Innovations in Lipid Nutrition for Neonates and Young Children
- S3. Protein Quality and Its Impact on Early Childhood Nutrition
- S4. Carbohydrates and Oligosaccharides in Early Nutrition
- S5. Micronutrients, Antioxidants, and Microbiota in Infant Health
- S6. Feeding Practices for Preterm and Term Infants
- Event Details
The IOCNu 2027 is Now OPEN for Abstract Submission and Registration, which are
free of charge for all participants.
Instructions for authors are available online.
Submit your abstracts HERE.
For any inquiries, please contact us at iocnu2027@mdpi.com.
Welcome from the Chairs
S1. Human Milk Composition and Its Role in Infant Development;
S2. Innovations in Lipid Nutrition for Neonates and Young Children;
S3. Protein Quality and Its Impact on Early Childhood Nutrition;
S4. Carbohydrates and Oligosaccharides in Early Nutrition;
S5. Micronutrients, Antioxidants, and Microbiota in Infant Health;
S6. Feeding Practices for Preterm and Term Infants.
Dr. Claude Billeaud, Hôpital des Enfants, CHU Pellegrin, Bordeaux, France, European Association for Paediatrics Education CEO
Dr. Francisco J. Pérez-Cano, University of Barcelona, Barcelona and Nutrition and Food Safety Research Institute (INSA), Spain
Event Chairs
Hôpital des Enfants, CHU Pellegrin, 33076 Bordeaux, France,
European Association for Paediatrics Education CEO
Claude Billeaud received his MD degree from the Medical University of Bordeaux (France) in 1979 after a graduation in human cytogenetics (1976). He then studied pediatrics and has been the Clinical Assistant Director of Bordeaux University in the departments of Pediatrics, Neonatology and Intensive Care since 1983. He currently serves as a pediatrician in the neonatal unit at the Children’s Hospital of Bordeaux, as a scientific manager of the Bordeaux-Marmande human milk bank, as a lecturer and head of research (HDR: Habilitation to direct research) in neonatal nutrition at the Medical University of Bordeaux. His particular interest in research led him to graduate in Biology and Health (1988, Bordeaux), be awarded a master in statistics applied to clinical research (1991, Montreal) and complete a PhD in nutrition and food science (2000, Bordeaux). Along his career, he has often been invited as a guest professor specialized in nutrition and neonatology in various universities abroad (Montreal, Corrientes in Argentina). Over the last 40 years, he has been deeply implicated in European pediatrics education, serving as President of the European Association for Paediatrics Education and as a member of the European Academy of Paediatrics. He has also been an active member of different scientific organizations, either French, European, or American, specialized in perinatal medicine (neonatology, pediatrics, and nutrition). He has been very involved in the French human milk banking association (ADLF) for more than 10 years, sharing his academic knowledge focused on nutrition and his long clinical experience in neonatology. He is currently carrying out several research projects on the composition of human milk.
Department of Biochemistry and Physiology, Faculty of Pharmacy and Food Sciences, University of Barcelona, Barcelona, Spain; Nutrition and Food Safety Research Institute (INSA), Santa Coloma de Gramenet, Spain
Francisco J Pérez-Cano was born and educated in Barcelona. He studied the degree of Pharmacy (1999) at the University of Barcelona (UB) where he also studied different masters in higher education. He joined in 1996 to the “Autoimmunity, Immunonutrition and Tolerance Research Group” in the Department of Physiology. He moved to the Center for Immunology at the University of California-Irvine in 2003-2004 to complete his training and he defended his PhD about “Mucosal Immunity Acquisition in Early Life” in 2004. After that, he was hired as associate professor (2005), Lecturer (2007) and finally as a Permanent Associate Professor (2011) in the Department of Physiology of the University of Barcelona. He is currently teaching different subjects in the Degrees of Pharmacy, Food Science and Technology, Human Nutrition and in several University Masters. He performed a post-doctoral training (2009) at the University of Reading (UK) and has participated in more than 50 research projects with public funding but also in collaboration with industry. Francisco has more than 120 peer-review manuscripts, a book and several book chapters in the field. Francisco’s research interests are Immunonutrition in early life. He has focused, on the one hand in the impact of cocoa, and its components, in immunity and microbiota in health conditions but also in disease by using models of acute/chronic inflammation and allergy. On the other hand, he has studied the impact of several components present in breast milk (whey proteins, lactoferrin, CLA, oligosaccharides, probiotic bacteria, etc.) at preclinical level on the developing immune function of infants but also under viral infections. His current line of research is focused on the effect of prebiotics, probiotics, postbiotics and its combinations on the neonatal immune system and the impact of maternal diet on immunity programming. Dr. Pérez-Cano is the director of the Research Institute for Nutrition and Safety-UB (INSA-UB), Ambassador of the Spanish Society of Immunology (SEI) and Section Chief Editor of “Nutritional Immunology”.
Sessions
S2. Innovations in Lipid Nutrition for Neonates and Young Children
S3. Protein Quality and Its Impact on Early Childhood Nutrition
S4. Carbohydrates and Oligosaccharides in Early Nutrition
S5. Micronutrients, Antioxidants, and Microbiota in Infant Health
S6. Feeding Practices for Preterm and Term Infants
Registration
The registration for IOCNu 2027 will be free of charge! The registration includes attendance to all conference sessions.
If you are registering several people under the same registration, please do not use the same email address for each person, but their individual university email addresses. Thank you for your understanding.
Please note that the submission and registration are two separate parts. Only scholars who registered can receive a link to access the conference live streaming.
The deadline for registration is 5 February 2026.
Instructions for Authors
- Deadline for abstract submission: 12 October 2026.
- Abstract acceptance notification: 10 November 2026.
An abstract acceptance email only confirms that your abstract has been accepted. Oral or poster presentation invitations are determined separately by the conference chairs, and you will receive an additional email with the presentation result.
- Types of Submissions
- Accepted: Original research abstracts; systematic reviews or meta-analyses abstracts (must comply with PRISMA 2020).
- Not accepted: Narrative, scoping, comparative, perspective, opinion, or essay-style reviews. - Content Requirements
- Length: 200–300 words.
- Structure: Introduction, Methods, Results, Conclusions.
- Language: Clear, publication-ready English.
- Originality: Must be original and unpublished; previously published abstracts will not be considered.
- The submitting author must ensure all co-authors approve the content.
- Authors may submit multiple abstracts, but only one abstract per author may be selected for an oral presentation.
1. Each abstract must designate one presenter. To change the presenter, please contact us after you receive the oral/poster presentation invitation.
2. Only live presentations are accepted.
3. Presenters who do not attend the live session will not be eligible for awards or presentation certificates.
- Use a clear and logical structure, typically Introduction-Methods-Results&Discussion structure (IMRaD) or a field-appropriate alternative;
- Emphasize the relevance of the work;
- Support key findings with clear figures or tables where appropriate;
- Conclude with a critical interpretation of the results and their impact.
- Brief introduction outlining the research objective;
- Concise methodology summary;
- Main results, supported by clear, well-labeled figures or tables where appropriate;
- Short conclusion summarizing key findings and their relevance.
Dimensions (cm): 84.1 × 118.9 (A0 - portrait)
Resolution:300 dpi
Pixel size (portrait, 300 dpi):9933 × 14043 px
Minimum font size:≥24
It is the author's responsibility to identify and declare any personal circumstances or interests that may be perceived as inappropriately influencing the representation or interpretation of clinical research. If there is no conflict, please state "The authors declare no conflicts of interest." This should be conveyed in a separate "Conflict of Interest" statement preceding the "Acknowledgments" and "References" sections at the end of the manuscript. Any financial support for the study must be fully disclosed in the "Acknowledgments" section.
MDPI, the publisher of the Sciforum.net platform, is an open access publisher. We believe authors should retain the copyright to their scholarly works. Hence, by submitting an abstract to this conference, you retain the copyright to the work, but you grant MDPI the non-exclusive right to publish this abstract online on the Sciforum.net platform. This means you can easily submit your full paper (with the abstract) to any scientific journal at a later stage and transfer the copyright to its publisher if required.
Publication Opportunities
- Nutrients Journal Publication
Participants in this conference are cordially invited to contribute a full manuscript to the conference's Special Issue (to be announced soon) published in Nutrients (ISSN: 2072-6643, Impact Factor 5), with a 20% discount on the publication fee. Please note that if you have IOAP/association discounts, conference discounts will be combined with IOAP/association discounts. Conference discounts cannot be combined with reviewer vouchers. All submitted papers will undergo MDPI’s standard peer-review procedure. The abstracts should be cited and noted on the first page of the paper. - Proceeding Paper Publication
Authors of accepted abstracts are highly encouraged to submit an extended proceedings paper (ideally 4–8 pages in length) for the conference's dedicated proceedings volume in the Biology and Life Sciences Forum (ISSN: 2673-9976) for free, please submit it after the conference. Authors are asked to disclose that it is a proceeding paper of the IOCNu2027 conference paper in their cover letter. Carefully read the rules outlined in the 'Instructions for Authors' on the journal’s website and ensure that your submission adheres to these guidelines.
Publication Notice: Proceedings papers will undergo peer-review procedure. Acceptance at the conference does not ensure final publication.
Proceedings submission deadline: 29 March 2027.
Manuscripts for the proceedings issue must be formatted as follows:
Title;
Full author names;
Affiliations (including full postal address) and authors' e-mail addresses;
Abstract;
Keywords;
Introduction;
Methods;
Results and Discussion;
Conclusions;
Acknowledgements;
References.
Please click HERE to submit your proceeding paper to the Biology and Life Sciences Forum, and be sure to disclose the conference information in your cover letter or mention the conference name in your submission.
IOCNU2027-Proceeding Paper-Template
Event Awards

To acknowledge the support of the conference's esteemed authors and recognize their outstanding scientific accomplishments, we are pleased to announce the establishment of the Best Oral Presentation Award and Best Poster Award.
The Awards
Number of Awards Available: 6
1. Best Oral Presentation Award
Eligibility: Open to all authors selected as oral speakers who have delivered their presentation. Failure to present, delegation of the presentation to another person, or use of AI-generated voice or similar substitutes will result in disqualification.
Criteria: Evaluation considers scientific rigor (clear, literature-supported research question or hypothesis, appropriate methodology, robust analysis and critical discussion of the results), IMRaD/field-appropriate structure, clarity of presented data (clear, well-labeled figures and tables), presentation skills and audience engagement, demonstrated scientific novelty and impact.
Prize: An award of CHF 200 and a certificate in recognition of your outstanding contribution.
Eligibility: Open to all authors who have presented their work through posters. Failure to present, delegation of the presentation to another person, or use of AI-generated voice or similar substitutes will result in disqualification.
Winner Announcement: The award winners will be evaluated and selected by the scientific committee after the conference. Results will be announced on the website and all winners will be individually contacted via email.
Sponsors and Partners
For information regarding sponsorship and exhibition opportunities, please click here.
Organizers
Co-organizers
Media Partners
Conference Secretariat
Ms. Ioana Vintila
Mr. Ionut Spatar
Mr. Russell Wang
Email: iocnu2027@mdpi.com
For inquiries regarding submissions and sponsorship opportunities, please feel free to contact us.


